GE Healthcare Ltd.

GE Healthcare Ltd. is an operating company and a subsidiary of the publicly traded GE HealthCare Technologies Inc. (Nasdaq: GEHC). The parent company, which was spun off from General Electric in January 2023, is headquartered in Chicago, Illinois. GE HealthCare employs over 51,000 people globally and reported revenue of $19.6 billion. While GE Healthcare Ltd. is a UK-based entity, its parent company has major operations worldwide.

GE HealthCare is a medical technology and diagnostics company. Its business is divided into four main segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The company develops, manufactures, and markets a wide range of products including MRI, CT, and X-ray imaging systems; handheld and console ultrasound devices; patient monitoring and anesthesia delivery systems; and contrast media and radiopharmaceuticals used in diagnostic procedures. The company serves hospitals and medical facilities in more than 160 countries.

As a major operating company, GE Healthcare's litigation profile is that of a technology producer defending its position. The available data shows the company acting as a plaintiff in two cases, both of which are administrative challenges to patent validity filed at the U.S. Patent Trial and Appeal Board (PTAB). This posture is common for large technology companies, which proactively challenge patents owned by others that may pose a risk to their products or freedom to operate. The filings are not in a typical litigation venue like a district court, but in a specialized administrative body.

The two tracked cases are petitions filed by GE Healthcare Ltd. against The Johns Hopkins University in 2025. These proceedings at the PTAB concern challenges to the validity of patents held by the university. The subject matter of the patents likely relates to medical imaging or diagnostic technologies relevant to GE HealthCare's product lines.